k-877
Small moleculeexperimental
Clinical trial activity
20 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
12
Phase 2
8
Phase 3
4
Phase 4
0
Earliest trial started Jan 1, 2014 (NCT02073084)
Timeline
Indications
Mechanism of action
PPARA agonist
Selective PPAR alpha modulator (SPPAR?M) properties. Ph3 in Japan
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3545412 ↗
Also known as
- k-877
- k-877
- k-877
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05923281 | Phase 3 | May 1, 2023 | Kowa |
| NCT05722262 | Phase 1 | Feb 24, 2023 | Kowa |
| NCT05327127 | Phase 2 | Nov 14, 2022 | Kowa |
| NCT04742218 | Phase 1 | Jan 13, 2021 | Kowa |
| NCT04447820 | Phase 2 | Jun 10, 2020 | Kowa |
| NCT04237597 | Phase 1 | Dec 17, 2019 | Kowa |
| NCT04079530 | Phase 2 | Sep 21, 2019 | Kowa |
| NCT03702673 | Phase 1 | Oct 5, 2018 | Kowa |
| NCT03350165 | Phase 2 | Dec 27, 2017 | Kowa |
| NCT03071692 | Phase 3 | Mar 23, 2017 | Harvard University, Kowa |
| NCT03001817 | Phase 3 | Nov 1, 2016 | Kowa |
| NCT03011450 | Phase 3 | Nov 1, 2016 | Kowa |
| NCT02922465 | Phase 1 | Sep 1, 2016 | Kowa |
| NCT02719431 | Phase 1 | Jan 1, 2016 | Kowa |
| NCT02275962 | Phase 1 | Sep 1, 2014 | Kowa |
| NCT02273986 | Phase 1 | Aug 1, 2014 | Kowa |
| NCT02275975 | Phase 1 | Jul 1, 2014 | Kowa |
| NCT02276001 | Phase 1 | Jun 1, 2014 | Kowa |
| NCT02275988 | Phase 1 | Jun 1, 2014 | Kowa |
| NCT02073084 | Phase 1 | Jan 1, 2014 | Kowa |
Showing 20 of 20 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Kowa | For profit | 20 | 20 | 3 | 2014 |
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 2017 |
2 organizations
Page 1 / 1